Amidst the global uncertainty stemming from COVID-19, many leading revenue cycle companies and investors have recognized this as a unique opportunity. While many in the industry are struggling with their clients’ decreased patient volumes, healthier businesses are pursuing opportunistic acquisitions and investing in their operational efficiencies to strengthen their go-to-market positioning.
How are some of our country’s more innovative revenue cycle management (“RCM”) services and software companies balancing this dynamic? How are they reinforcing their own internal operations? What types of acquisition targets are most desirable in the current climate? What structural elements and financing tools are they considering? How does COVID-19 impact their view of the future of the RCM industry? We have assembled a panel of experts for an exclusive webinar on these and more topics.
· Jonathan Bluth, Director, Co-Head of Healthcare, Intrepid
· Bill Korn, Chief Financial Officer, MTBC
· Stephen Grubbs, Chief Executive Officer, Coronis Health
· Matthew Carroll, General Partner, WestView Capital